Philipp Schlegel

AAV6. ARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model

Philip Raake, Philipp Schlegel, Jan Ksienzyk et al. · European Heart Journal · 2012 · 158 citations · Full text

CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression

Henrike Tscheschner, Eric Meinhardt, Philipp Schlegel et al. · PLoS ONE · 2019 · 57 citations · Full text

Doxorubicin Cardiotoxicity, Ca2+ Homeostasis, Cardiac Muscle +20

G protein-coupled receptor kinase 2 promotes cardiac hypertrophy

Philipp Schlegel, J. Reinkober, Eric Meinhardt et al. · PLoS ONE · 2017 · 39 citations · Full text

Cardiac Muscle, Heart Failure, Cardiovascular Function +18

Initial Experience with Transcatheter Tricuspid Valve Repair in Patients with Cardiac Amyloidosis

Isabel A. Hoerbrand, Martin Volz, Fabian aus dem Siepen et al. · ESC Heart Failure · 2022 · 15 citations · Full text

Locally Targeted Cardiac Gene Delivery by AAV Microbubble Destruction in a Large Animal Model

Philipp Schlegel, Regina Huditz, Eric Meinhardt et al. · Human Gene Therapy Methods · 2016 · 10 citations

Cardiac Gene Delivery, Transgene Expression, Immunology +19